Wen-Hung Chung
Overview
Explore the profile of Wen-Hung Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
250
Citations
5236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen C, Hung S, Chang J, Yang C, Ma D, Teng Y, et al.
Nat Commun
. 2024 Dec;
15(1):10733.
PMID: 39737932
Immune checkpoint inhibitors (ICI) represent new anticancer agents and have been used worldwide. However, ICI can potentially induce life-threatening severe cutaneous adverse reaction (SCAR), such as Stevens-Johnson syndrome/toxic epidermal necrolysis...
2.
Lee C, Huang Y, Chi C, Chung W, Chen C
Trends Immunol
. 2024 Dec;
46(1):74-89.
PMID: 39732527
Generalized pustular psoriasis (GPP) is a rare human autoinflammatory disorder with life-threatening systemic effects. Keratinocyte-derived interleukin (IL)-36 signaling has been identified as a key mediator of immune response in the...
3.
Lu K, Lee H, Chen C, Hui R, Chang Y, Lu C, et al.
Front Immunol
. 2024 Dec;
15:1506962.
PMID: 39650667
Introduction: Both cellular and humoral responses are important for vaccine protection, but recommendations on immunosuppressants in dermatology are largely based on pre-pandemic experiences. This study aimed to investigate the impacts...
4.
Calzavara-Pinton P, Chu C, Lapeere H, Rossi M, Ferrucci S, Chung W, et al.
Adv Ther
. 2024 Dec;
42(2):720-733.
PMID: 39621227
Introduction: Currently, limited data are available on long-term use of dupilumab to treat atopic dermatitis (AD) in a multinational real-world setting. The aim of this analysis was to report the...
5.
Tiongco-Recto M, Woo K, Chung W, Chua G, Godse K, Gabriel M, et al.
World Allergy Organ J
. 2024 Nov;
17(11):100984.
PMID: 39553289
Background: Chronic urticaria (CU), in both inducible and spontaneous forms, is associated with a substantial burden in the Asia-Pacific region (APAC). Patient-centred care recognises patients desire to be involved in...
6.
Chen C, Wang C, Lu C, Chen W, Zhou B, Chu C, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
13(1):143-154.e10.
PMID: 39505105
Background: Osimertinib, a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), shows superior lung cancer treatment efficacy. However, osimertinib-induced severe hypersensitivity, including Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), is frequently...
7.
Chiu T, Chen C, Lu C, Hui R, Chi M, Chang Y, et al.
Br J Dermatol
. 2024 Nov;
192(2):293-305.
PMID: 39503255
Background: As a drug-induced hypersensitivity syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) is potentially fatal. Most patients with DRESS recover within a few weeks; however, some patients may...
8.
Lei W, Lo Y, Tsumura M, Ding J, Lo C, Lin Y, et al.
J Clin Immunol
. 2024 Aug;
44(8):184.
PMID: 39177867
Purpose: Heterozygous STAT1 Gain-of-Function (GOF) mutations are the most common cause of chronic mucocutaneous candidiasis (CMC) among Inborn Errors of Immunity. Clinically, these mutations manifest as a broad spectrum of...
9.
Lu C, Chen C, Chiu T, Chen C, Wei K, Lin S, et al.
J Formos Med Assoc
. 2024 Aug;
PMID: 39174397
The 2023 consensus from the Taiwanese Dermatological Association (TDA) and Taiwan Lung Cancer Society (TLCS) addresses the management of tyrosine kinase inhibitor (TKI)-induced skin toxicities in non-small cell lung cancer...
10.
Wu P, Huang I, Wang C, Chung W, Chen C
Dermatitis
. 2024 Aug;
PMID: 39172639
The outbreak of COVID-19 pandemic has raised urgent vaccine development to prevent viral transmission. Cutaneous adverse events such as erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN)...